29 results
Thumbnail

D3.274 - Feasibility of Digestive Enzyme Supplementation for Cow’s Milk Allergy in Exclusively Breastfed Infants

Thumbnail

D3.270 - Recent Trends in Food Allergy among Schoolchildren in a South Korean City (2018–2022)

Thumbnail

D3.271 - Development of a multiplex assay to assess the risk of IgE cross-reactivity to new protein sources

Thumbnail

D3.272 - Selective Sensitization to Prawn with Absence of Cross-Reactivity to Fish: Molecular Identification of Hemocyanin (Pen m 7) and Sarcoplasmic Calcium-Binding Protein (Pen m 4) in a Patient with Recurrent Urticaria

Thumbnail

D3.273 - Longitudinal Changes in Severity in Children with Severe, Refractory Cow’s Milk Allergy

Thumbnail

D3.275 - In silico based assessment of intrinsic protein features for ranking clinical relevance of plant-based food allergens

Thumbnail

D3.277 - Tolerance to canned fish in patients allergic to β -parvalbumins

Thumbnail

D3.278 - Tropomyosin-Driven Cross-Reactivity Between Shellfish and House Dust Mites: A Case Report

Thumbnail

D3.279 - SWEET HONEY AND SOUR ALLERGIES: POLLEN-FOOD DEFENSIN CROSS-REACTIVITY - a case series

Thumbnail

D3.281 - A Challenging Case of Paediatric Potato Allergy with Discordant Diagnostic Findings

Thumbnail

D3.282 - A Case of Nonsteroidal Anti-Inflammatory Drug-Exacerbated Food Allergy

Thumbnail

D3.280 - Severe Anaphylaxis Induced by Turkey Egg with Tolerance to Hen’s Egg and Poultry Meat: A First Report

Thumbnail

D3.440 - Long-Term Efficacy and Safety of Donidalorsen for Hereditary Angioedema Among Patients in Europe: A Regional Analysis of the OASISplus Study

Thumbnail

D3.441 - Switching to Donidalorsen for Hereditary Angioedema: 1-Year Results From the Phase 3 OASISplus Study

Thumbnail

D3.444 - Efficacy and Safety of Donidalorsen for Patients With Hereditary Angioedema in Europe Who Switched From Prior Long-Term Prophylaxis: Results From the OASISplus Study

Thumbnail

D3.445 - Validation of a Novel Serum-Based Indirect Basophil Activation Test (iBAT) to Evaluate Efficacy of a Pivotal Phase III PQ Grass Immunotherapy Trial

Thumbnail

D3.437 - Impact of benralizumab on fatigue and health-related quality of life in patients with hypereosinophilic syndrome: findings from the NATRON phase 3 trial

Thumbnail

D3.438 - Clinical outcomes with navenibart according to baseline attack rate, body mass index, and age: results of the ALPHA-STAR trial

Thumbnail

D3.439 - Donidalorsen For The Treatment Of Hereditary Angioedema: 1-Year Results From The OASISplus Open-Label Extension Cohort

Thumbnail

D3.442 - Patient-Reported Outcomes With Long-Term Donidalorsen Treatment Among Patients In Europe With Hereditary Angioedema: 1-Year Interim Results From The OASISplus Open-Label Extension Cohort